This precancerous condition can progress to active multiple myeloma, a type of blood cancer. High-risk SMM carries a higher likelihood of progression. Smoldering multiple myeloma is a condition in ...

Myeloma specialist Dr. Urvi Shah is researching the role that whole-food and plant-based diets may play in slowing the progression of certain conditions into multiple myeloma. Many people who are ...

Several new studies highlight the significant impact of dietary choices on cancer progression and prevention, particularly concerning multiple myeloma and gastrointestinal (GI) cancers. The first, a ...

Myeloma, or multiple myeloma, is a cancer affecting a particular type of blood cells, called plasma cells. Myeloma is most common in people over 60 and is characterized by the accumulation of ...

While many treatments are available for multiple myeloma, frequent relapse in this type of blood cancer means patients need new treatment options that take different approaches to the disease.

Northwell Health has appointed David J. Chung, MD, PhD, a prominent oncologist-investigator, as director of clinical research at the Northwell Health Cancer Institute. In this newly created role, Dr.

Dana-Farber Cancer Institute investigators are leading three separate studies with encouraging results related to the early detection and interception of multiple myeloma. The research teams will ...

response criteria for multiple myeloma, said the study's lead author, Rahul Banerjee, MD, from Fred Hutch Cancer Center, University of Washington School of Medicine, Seattle. "International ...

The overall response rate was 43.3% in the 1.5 mg/kg dose group and 42.9% in the 3.0 mg/kg dose group. Modakafusp alfa “warrants continued exploration” as a treatment for patients with ...